UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure

American journal of ophthalmology, 2000-06, Vol.129 (6), p.723-727

2000

Volltextzugriff (PDF)

Twenty-four–hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination

Ophthalmology (Rochester, Minn.), 2003-07, Vol.110 (7), p.1357-1360

2003

Volltextzugriff (PDF)

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma : a six-month, masked, multicenter trial in the United States

Ophthalmology (Rochester, Minn.), 1996, Vol.103 (1), p.138-147

CAMRAS, C. B

1996

Volltextzugriff (PDF)

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

American journal of ophthalmology, 1999-07, Vol.128 (1), p.15-20

1999

Volltextzugriff (PDF)

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol

American journal of ophthalmology, 2002-06, Vol.133 (6), p.753-757

2002

Volltextzugriff (PDF)

Washout periods for brimonidine 0.2% and latanoprost 0.005

American journal of ophthalmology, 2001-06, Vol.131 (6), p.798-799

2001

Volltextzugriff (PDF)

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma

American journal of ophthalmology, 2001-06, Vol.131 (6), p.729-733

2001

Volltextzugriff (PDF)

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension

American journal of ophthalmology, 2003-02, Vol.135 (2), p.138-143

2003

Volltextzugriff (PDF)

Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost

American journal of ophthalmology, 1999-12, Vol.128 (6), p.692-696

1999

Volltextzugriff (PDF)

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005

American journal of ophthalmology, 2001-03, Vol.131 (3), p.339-344

2001

Volltextzugriff (PDF)

Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol

American journal of ophthalmology, 1998-09, Vol.126 (3), p.390-399

1998

Volltextzugriff (PDF)

Can patients guess their intraocular pressure?

American journal of ophthalmology, 2004-02, Vol.137 (2), p.350-351

2004

Volltextzugriff (PDF)

Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma

American journal of ophthalmology, 1999-02, Vol.127 (2), p.142-147

1999

Volltextzugriff (PDF)

Serum Lipid Physiology and the Influence of Glaucoma Medications

Survey of Ophthalmology, 1998-11, Vol.43 (3), p.233-244

1998

Volltextzugriff (PDF)

Cardiovascular Effects of Topical Carteolol Hydrochloride and Timolol Maleate in Patients With Ocular Hypertension and Primary Open-angle Glaucoma

American journal of ophthalmology, 1997-04, Vol.123 (4), p.465-477

1997

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Collection

ThemaEye

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Kollektion

Ingenta.com
(15)
Access via ScienceDirect (Elsevier)
(15)
MEDLINE
(12)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1)
IngentaConnect Journals
(1)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure

Twenty-four–hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma : a six-month, masked, multicenter trial in the United States

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol

Washout periods for brimonidine 0.2% and latanoprost 0.005

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension

Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005

Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol

Can patients guess their intraocular pressure?

Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma

Serum Lipid Physiology and the Influence of Glaucoma Medications

Cardiovascular Effects of Topical Carteolol Hydrochloride and Timolol Maleate in Patients With Ocular Hypertension and Primary Open-angle Glaucoma

Aktive Filter

Suchergebnisse filtern